Literature DB >> 18453587

Signaling mechanism of HIV-1 gp120 and virion-induced IL-1beta release in primary human macrophages.

Ricky Cheung1, Vipa Ravyn, Lingshu Wang, Andrzej Ptasznik, Ronald G Collman.   

Abstract

HIV-1 envelope glycoprotein gp120 induces, independently of infection, the release of proinflammatory cytokines, including IL-1beta from macrophages, that are implicated in the pathogenesis of HIV-associated dementia. However, the signal transduction pathways involved have not been fully defined. Previously, our laboratory reported that soluble gp120 activates multiple protein kinases in primary human monocyte-derived macrophages, including the Src family kinase Lyn, PI3K, and the focal adhesion-related proline-rich tyrosine kinase Pyk2. In this study we showed that gp120 induces IL-1beta release from macrophages in a time- and concentration-dependent manner through binding to the chemokine receptor CCR5 and coupling to G(i)alpha protein. Using pharmacological inhibitors and small interfering RNA gene knockdown, we demonstrated that concomitant activation of Lyn, Pyk2, and class IA PI3K are required for gp120-induced IL-1beta production. By coimmunoprecipitation and immunofluorescence confocal microscopy, we showed that CCR5 activation by gp120 triggered the assembly of a signaling complex involving endogenous Lyn, PI3K, and Pyk2 and is associated with PI3K and Pyk2 translocation from the cytoplasm to the membrane where they colocalized with Lyn. Finally, we demonstrated that virion-associated gp120 induced similar response, as structurally intact whole virions also triggered IL-1beta release and re-localization of PI3K and Pyk2. This study identifies a novel signaling mechanism for HIV-1-induced IL-1beta production by primary human macrophages that may be involved in the neuropathogenesis of HIV-associated dementia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18453587      PMCID: PMC2375537          DOI: 10.4049/jimmunol.180.10.6675

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  75 in total

1.  Chemokine receptor CCR5 functionally couples to inhibitory G proteins and undergoes desensitization.

Authors:  J Zhao; L Ma; Y L Wu; P Wang; W Hu; G Pei
Journal:  J Cell Biochem       Date:  1998-10-01       Impact factor: 4.429

2.  Activation of protein tyrosine kinase PYK2 by the m1 muscarinic acetylcholine receptor.

Authors:  J S Felsch; T G Cachero; E G Peralta
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

3.  Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage.

Authors:  H Adle-Biassette; F Chrétien; L Wingertsmann; C Héry; T Ereau; F Scaravilli; M Tardieu; F Gray
Journal:  Neuropathol Appl Neurobiol       Date:  1999-04       Impact factor: 8.090

4.  Involvement of interleukin-1beta in the mechanism of human immunodeficiency virus type 1 (HIV-1) recombinant protein gp120-induced apoptosis in the neocortex of rat.

Authors:  G Bagetta; M T Corasaniti; L Berliocchi; R Nisticó; A M Giammarioli; W Malorni; L Aloe; A Finazzi-Agró
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

Review 5.  The neuropathogenesis of AIDS.

Authors:  Francisco González-Scarano; Julio Martín-García
Journal:  Nat Rev Immunol       Date:  2005-01       Impact factor: 53.106

6.  Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis.

Authors:  Montserrat Camps; Thomas Rückle; Hong Ji; Vittoria Ardissone; Felix Rintelen; Jeffrey Shaw; Chiara Ferrandi; Christian Chabert; Corine Gillieron; Bernard Françon; Thierry Martin; Denise Gretener; Dominique Perrin; Didier Leroy; Pierre-Alain Vitte; Emilio Hirsch; Matthias P Wymann; Rocco Cirillo; Matthias K Schwarz; Christian Rommel
Journal:  Nat Med       Date:  2005-08-28       Impact factor: 53.440

7.  PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus.

Authors:  Domingo F Barber; Almira Bartolomé; Carmen Hernandez; Juana M Flores; Clara Redondo; Cristina Fernandez-Arias; Montserrat Camps; Thomas Rückle; Matthias K Schwarz; Santiago Rodríguez; Carlos Martinez-A; Dimitrios Balomenos; Christian Rommel; Ana C Carrera
Journal:  Nat Med       Date:  2005-08-28       Impact factor: 53.440

8.  The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 phosphatidylinositol 3-kinase and the class II PI3K-C2alpha.

Authors:  S J Turner; J Domin; M D Waterfield; S G Ward; J Westwick
Journal:  J Biol Chem       Date:  1998-10-02       Impact factor: 5.157

Review 9.  The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens.

Authors:  R Wyatt; J Sodroski
Journal:  Science       Date:  1998-06-19       Impact factor: 47.728

Review 10.  Interleukin-1 and neuronal injury.

Authors:  Stuart M Allan; Pippa J Tyrrell; Nancy J Rothwell
Journal:  Nat Rev Immunol       Date:  2005-08       Impact factor: 53.106

View more
  43 in total

Review 1.  Genetic knockouts suggest a critical role for HIV co-receptors in models of HIV gp120-induced brain injury.

Authors:  Ricky Maung; Kathryn E Medders; Natalia E Sejbuk; Maya K Desai; Rossella Russo; Marcus Kaul
Journal:  J Neuroimmune Pharmacol       Date:  2011-11-29       Impact factor: 4.147

2.  Methamphetamine and HIV-1 gp120 effects on lipopolysaccharide stimulated matrix metalloproteinase-9 production by human monocyte-derived macrophages.

Authors:  Jessica L Reynolds; Supriya D Mahajan; Ravikumar Aalinkeel; Bindukumar Nair; Donald E Sykes; Stanley A Schwartz
Journal:  Immunol Invest       Date:  2011-03-22       Impact factor: 3.657

3.  Mechanism of HIV-1-TAT induction of interleukin-1beta from human monocytes: Involvement of the phospholipase C/protein kinase C signaling cascade.

Authors:  Yongbo Yang; Jianguo Wu; Yuanan Lu
Journal:  J Med Virol       Date:  2010-05       Impact factor: 2.327

Review 4.  Mitogen-activated protein kinase p38 in HIV infection and associated brain injury.

Authors:  Kathryn E Medders; Marcus Kaul
Journal:  J Neuroimmune Pharmacol       Date:  2011-02-01       Impact factor: 4.147

Review 5.  A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection.

Authors:  Stephanie D Kraft-Terry; Shilpa J Buch; Howard S Fox; Howard E Gendelman
Journal:  Neuron       Date:  2009-10-15       Impact factor: 17.173

Review 6.  Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages.

Authors:  Davide Gibellini; Alberto Clò; Silvia Morini; Anna Miserocchi; Cristina Ponti; Maria Carla Re
Journal:  World J Virol       Date:  2013-05-12

Review 7.  Childhood maltreatment and HIV-associated neurocognitive disorders share similar pathophysiology: a potential sensitisation mechanism?

Authors:  Jacqueline S Womersley; Soraya Seedat; Sian M J Hemmings
Journal:  Metab Brain Dis       Date:  2017-07-05       Impact factor: 3.584

Review 8.  Morphine and rapid disease progression in nonhuman primate model of AIDS: inverse correlation between disease progression and virus evolution.

Authors:  Vanessa Rivera-Amill; Peter S Silverstein; Richard J Noel; Santosh Kumar; Anil Kumar
Journal:  J Neuroimmune Pharmacol       Date:  2009-12-16       Impact factor: 4.147

9.  An arrestin-dependent multi-kinase signaling complex mediates MIP-1beta/CCL4 signaling and chemotaxis of primary human macrophages.

Authors:  Ricky Cheung; Mobeen Malik; Vipa Ravyn; Brian Tomkowicz; Andrzej Ptasznik; Ronald G Collman
Journal:  J Leukoc Biol       Date:  2009-07-20       Impact factor: 4.962

Review 10.  CNS inflammation and macrophage/microglial biology associated with HIV-1 infection.

Authors:  Anjana Yadav; Ronald G Collman
Journal:  J Neuroimmune Pharmacol       Date:  2009-09-19       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.